Literature DB >> 6313915

Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients.

E M Rivadeneira, M Wasserman, C T Espinal.   

Abstract

A technique for the separation of schizonts of Plasmodium falciparum is described. The different stages of the asexual cell cycle of the parasite were positioned according to their density in a continuous gradient of Percoll. Young trophozoites coincided with erythrocytes in a broad band corresponding to densities from 1.075 to 1.100 g/ml, whereas schizonts were concentrated at a density approximating 1.062 g/ml. The viability of the parasites was unimpaired by this procedure. Young trophozoites and schizonts continued their normal life cycle when cultured after the separation procedure. The percentage of recovery was high, reaching 80% of the initial quantity. Possible applications of the technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313915     DOI: 10.1111/j.1550-7408.1983.tb02932.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  46 in total

1.  Oxidative damage of erythrocytes infected with Plasmodium falciparum. An in vitro study.

Authors:  K Mohan; N K Ganguly; M L Dubey; R C Mahajan
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

2.  Role of calcium and erythrocyte cytoskeleton phosphorylation in the invasion of Plasmodium falciparum.

Authors:  M Wasserman; J P Vernot; P M Mendoza
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Viability Screen of LOPAC1280 Reveals Tyrosine Kinase Inhibitor Tyrphostin A9 as a Novel Partner Drug for Artesunate Combinations To Target the Plasmodium falciparum Ring Stage.

Authors:  Sarah E L Ang; Esther H N Tan; Jie Xin Tong; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  In vitro interaction between Plasmodium falciparum myosin B (PfMyoB) and myosin A tail interacting protein (MTIP).

Authors:  Paula C Hernández; Moisés Wasserman; Jacqueline Chaparro-Olaya
Journal:  Parasitol Res       Date:  2018-08-09       Impact factor: 2.289

5.  Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum.

Authors:  Vinay Bulusu; Vijay Jayaraman; Hemalatha Balaram
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

6.  Chemical Determinants of antimalarial activity of reversed siderophores.

Authors:  A Tsafack; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Infection of mosquitoes from in vitro cultivated Plasmodium knowlesi H strain.

Authors:  Jennifer S Armistead; Roberto R Moraes Barros; Tyler J Gibson; Whitney A Kite; J Patrick Mershon; Lynn E Lambert; Sachy E Orr-Gonzalez; Juliana M Sá; John H Adams; Thomas E Wellems
Journal:  Int J Parasitol       Date:  2018-04-30       Impact factor: 3.981

8.  Decreased level of 2,3-diphosphoglycerate and alteration of structural integrity in erythrocytes infected with Plasmodium falciparum in vitro.

Authors:  M L Dubey; Ramakrishna Hegde; N K Ganguly; R C Mahajan
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

9.  Alterations in early cytokine-mediated immune responses to Plasmodium falciparum infection in Tanzanian children with mineral element deficiencies: a cross-sectional survey.

Authors:  Erasto V Mbugi; Marjolein Meijerink; Jacobien Veenemans; Prescilla V Jeurink; Matthew McCall; Raimos M Olomi; John F Shao; Hans Verhoef; Huub Fj Savelkoul
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

10.  Effect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparum infection.

Authors:  Erasto V Mbugi; Marjolein Meijerink; Jacobien Veenemans; Prescilla V Jeurink; Matthew McCall; Raimos M Olomi; John F Shao; Jaffu O Chilongola; Hans Verhoef; Huub F J Savelkoul
Journal:  Malar J       Date:  2010-06-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.